PhRMA Must Tackle Cost-Effectiveness “Dilemma,” J&J’s Weldon Says
Executive Summary
The Pharmaceutical Research & Manufacturers of America is considering the development of principles on evidence-based medicine to help it engage more directly in the debate over the cost-effectiveness of medicines
You may also be interested in...
PhRMA Patient Assistance Plan Is Template For Future Initiatives – BMS’ Dolan
PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested
PhRMA Patient Assistance Plan Is Template For Future Initiatives – BMS’ Dolan
PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested
PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions
The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians